Next Article in Journal
Impact of Adenovirus E4-ORF3 Oligomerization and Protein Localization on Cellular Gene Expression
Previous Article in Journal
Influence of Cellular Trafficking Pathway on Bluetongue Virus Infection in Ovine Cells
Article Menu

Export Article

Open AccessArticle
Viruses 2015, 7(5), 2404-2427; doi:10.3390/v7052404

A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue)

1
Unither Virology LLC, Silver Spring, MD 20910, USA
2
La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA
3
Oxford Glycobiology Institute, Oxford OX1 3QU, UK,
4
Gary Wolfe Toxicology, Herndon, VA 20170, USA
5
Tam Nguyen LLC, Gaithersburg, MD 20879, USA
6
Integrated Biotherapeutics, Gaithersburg, MD 20878, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Curt Hagedorn
Received: 16 March 2015 / Accepted: 7 May 2015 / Published: 13 May 2015
(This article belongs to the Section Antivirals & Vaccines)
View Full-Text   |   Download PDF [984 KB, uploaded 13 May 2015]   |  

Abstract

Iminosugars are capable of targeting the life cycles of multiple viruses by blocking host endoplasmic reticulum α-glucosidase enzymes that are required for competent replication of a variety of enveloped, glycosylated viruses. Iminosugars as a class are approved for use in humans with diseases such as diabetes and Gaucher’s disease, providing evidence for safety of this class of compounds. The in vitro antiviral activity of iminosugars has been described in several publications with a subset of these demonstrating in vivo activity against flaviviruses, herpesviruses, retroviruses and filoviruses. Although there is compelling non-clinical in vivo evidence of antiviral efficacy, the efficacy of iminosugars as antivirals has yet to be demonstrated in humans. In the current study, we report a novel iminosugar, UV-12, which has efficacy against dengue and influenza in mouse models. UV-12 exhibits drug-like properties including oral bioavailability and good safety profile in mice and guinea pigs. UV-12 is an example of an iminosugar with activity against multiple virus families that should be investigated in further safety and efficacy studies and demonstrates potential value of this drug class as antiviral therapeutics. View Full-Text
Keywords: glucosidase; glycosylation; Flaviviridae; flavivirus; Orthomyxoviridae; orthomyxovirus; mouse glucosidase; glycosylation; Flaviviridae; flavivirus; Orthomyxoviridae; orthomyxovirus; mouse
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Warfield, K.L.; Plummer, E.; Alonzi, D.S.; Wolfe, G.W.; Sampath, A.; Nguyen, T.; Butters, T.D.; Enterlein, S.G.; Stavale, E.J.; Shresta, S.; Ramstedt, U. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue). Viruses 2015, 7, 2404-2427.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top